Clinical Trials
46 trialscruciall
Second Affiliated Hospital, School of Medicine, Zhejiang University
SAVE-GEJ
Peking University People's Hospital
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer
Fudan University
NIVO402025
Blokhin's Russian Cancer Research Center
Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.
Zhejiang Provincial People's Hospital
Ultralow Dose PET Imaging of 18F-FDOPA
Nuclear Imaging Institute
PIPAC in Gastric Peritoneal Metastasis
Chinese University of Hong Kong
HVA-MPAL
Guangdong Second Provincial General Hospital
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study
Sun Yat-sen University
NeoMARS
Peking University
ELPIS
Yonsei University
Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies
University of Vermont Medical Center
Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
Peking University First Hospital
Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy
Instituto Oncoclinicas
Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
DZ-002-201
Hoag Memorial Hospital Presbyterian
HORIZON
Mayo Clinic
Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma
Peking University
TRANSFORM-GBC
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression
Tomsk National Research Medical Center of the Russian Academy of Sciences
Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107
Tomsk National Research Medical Center of the Russian Academy of Sciences
Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Tau PET Outcomes With Anti-amyloid Immunotherapies
Mayo Clinic
SAFIR3LibHERty
UNICANCER
Personalized SBRT in Early-Stage Peripheral NSCLC
Tianjin Medical University Cancer Institute and Hospital
Sonodynamic-Chemoradiotherapy Integration in Glioblastoma
The First Affiliated Hospital of Zhengzhou University
68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses
Peking Union Medical College Hospital
IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma
The First Affiliated Hospital of Xiamen University
Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis
The First Affiliated Hospital of Zhengzhou University
GUIDANCE
University of Cologne
GALENT-BT
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Pediatric Transplantation & Cellular Therapy Consortium
EXCEL
Pediatric Transplantation & Cellular Therapy Consortium
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment
St. Petersburg State Pavlov Medical University
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University
ECCO
Chongqing University Cancer Hospital
CISART
Fujian Medical University Union Hospital
Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University
A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor
Peking Union Medical College Hospital
Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer
Englewood Hospital and Medical Center
T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
Zhejiang Cancer Hospital
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
Rigshospitalet, Denmark
Neoadjuvant Fluzoparib Combined With Camrelizumab in Germline BRCA-mutated HER2-negative Breast Cancer
Peking University People's Hospital
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
The Methodist Hospital Research Institute
OPEB-01
Yonsei University
iStopMM
Landspitali University Hospital